EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2009-10-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-009-1264-0PMID 19838705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

  2008cited by this paper
• Abnormal metabolic networks in atypical parkinsonism

  2008cited by this paper
• Positron emission tomography imaging in dementia.

  2007cited by this paper
• The use of SPECT and PET in routine clinical practice in epilepsy

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• Rapid scanning protocol for brain (18)F-FDG PET: a validation study.

  2005cited by this paper
• FDG PET in the differential diagnosis of parkinsonian disorders

  2005cited by this paper
• The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies.

  2004cited by this paper
• Radiation exposure during transmission measurements: comparison between CT- and germanium-based techniques with a current PET scanner

  2003cited by this paper
• The FDG lumped constant in normal human brain.

  2002cited by this paper
• Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET

  2002cited by this paper
• European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.

  2002cited by this paper
• Metabolic correlates of levodopa response in Parkinson’s disease

  2001cited by this paper
• Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation

  2001cited by this paper
• Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET

  2001cited by this paper
• Positron emission tomography imaging of dementia

  2000cited by this paper
• PET: the merging of biology and imaging into molecular imaging.

  2000cited by this paper
• [Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose].

  2000cited by this paper
• Comparison of Different Methods for Attenuation Correction in Brain PET: Influence on the Calculation of the Metabolic Glucose Rate

  2000cited by this paper
• The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.

  1999cited by this paper
• The effect of vigabatrin (γ-vinyl GABA) on cerebral blood flow and metabolism

  1999cited by this paper
• Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine

  1999cited by this paper
• No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.

  1999cited by this paper
• 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

  1999cited by this paper
• Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

  1998cited by this paper
• Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.

  1998cited by this paper
• Klinische Wertigkeit der Positronen-Emissions-Tomographie in der Neuromedizin Positionspapier zu den Ergebnissen einer interdisziplinären Konsensuskonferenz

  1998cited by this paper
• [Clinical value of positron emission tomography in neuromedicine. Position paper on results of an interdisciplinary consensus conference].

  1998cited by this paper
• Human Brain Function

  1998cited by this paper
• Regional Differences in Cerebral Blood Flow and Glucose Utilization in Diabetic Man: The Effect of Insulin

  1998cited by this paper
• Estimated radiation dose to the newborn in FDG-PET studies.

  1996influential reference
• Ethical clinical practice of functional brain imaging. Society of Nuclear Medicine Brain Imaging Council.

  1996cited by this paper
• Clinical brain radionuclide imaging studies.

  1995cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography.

  1994cited by this paper
• Automated detection of the intercommissural line for stereotactic localization of functional brain images.

  1993cited by this paper
• Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.

  1993cited by this paper
• Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy.

  1993cited by this paper
• Society of Nuclear Medicine

  1988cited by this paper

• Acute effects of selective serotonin reuptake inhibitors on cerebral glucose metabolism and blood flow

  2026cites this paper
• Mapping brain changes in post-COVID-19 cognitive decline via FDG PET hypometabolism and EEG slowing

  2025cites this paper
• Relationships Between Brain Glucose Metabolism Patterns and Impaired Glycemic Status: A Systematic Review of FDG‐PET Studies With a Focus on Alzheimer's Disease

  2025cites this paper
• The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease

  2025influential citation
• Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages

  2025cites this paper
• Mapping the neural correlates of the effect of psycholinguistic variables on picture naming performance: a FDG-PET study across neurodegenerative diseases

  2025cites this paper
• MEPs and MRI Motor Band Sign as Potential Complementary Markers of Upper Motor Neuron Involvement in Amyotrophic Lateral Sclerosis

  2025cites this paper
• Brain glucose metabolism in patients with traumatic brain injury undergoing rehabilitation: a longitudinal 18F-FDG PET study

  2025cites this paper
• Progress and prospects of Parkinson’s disease with depression research: A global bibliometric analysis based on CiteSpace

  2025cites this paper
• Comparison of Deuterium Metabolic Imaging with FDG PET in Alzheimer Disease.

  2025cites this paper
• Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer´s disease in the clinical practice

  2025cites this paper
• Detection of Alzheimer's disease using 3D-CNN model based on multimodal connectome

  2025cites this paper
• FDG PET of the brain to screen for neurodegenerative disease in older liver transplant candidates

  2025cites this paper
• Incremental Prognostic Value of Hippocampal Metabolic Activity for Sudden Cardiac Death in Patients With Heart Failure With Reduced Ejection Fraction

  2025cites this paper
• Patch-Wise Intensity Mapping for Individualized Brain Abnormality Detection in Alzheimer's Disease

  2025cites this paper
• Enhancing interpretability of AI with radiomics-based deep neural network: proof of concept in the classification of Parkinsonian syndromes with 18F-FDG PET imaging

  2025cites this paper
• Learnable confidence-driven asymmetric attention fusion mechanism for PET/CT tumor segmentation

  2025cites this paper
• Bridging Genotype to Phenotype in KMT5B-Related Syndrome: Evidence from RNA-Seq, 18FDG-PET, Clinical Deep Phenotyping in Two New Cases, and a Literature Review

  2025cites this paper
• Sex‐related differences in amyotrophic lateral sclerosis: A 2‐[ 18F]FDG‐PET study

  2024cites this paper
• Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation

  2024cites this paper
• Data-driven prediction of regional brain metabolism using neuropsychological assessment in Alzheimer's disease and behavioral variant Frontotemporal dementia.

  2024cites this paper
• Thai national guideline for nuclear medicine investigation in movement disorders: Nuclear medicine society of Thailand, the neurological society of Thailand, and Thai medical physicist society collaboration

  2024cites this paper
• Major depression mistaken as frontotemporal dementia due to PET scan

  2024cites this paper
• Data-driven analysis of regional brain metabolism in behavioral frontotemporal dementia and late-onset primary psychiatric diseases with frontal lobe syndrome: A PET/MRI study.

  2024cites this paper
• Individual cerebellar metabolic connectome in patients with MTLE and NTLE associated with surgical prognosis

  2024cites this paper
• SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0.

  2024cites this paper
• Investigation of the effectiveness of no-reference metric in image evaluation in nuclear medicine

  2024cites this paper
• Thai Guideline for Nuclear Medicine Investigations of Neurocognitive Disorders: Nuclear Medicine Society of Thailand, the Neurological Society of Thailand, and Thai Medical Physicist Society Collaboration

  2024cites this paper
• Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait

  2024cites this paper
• Impact of cognitive impairment on heart failure prognosis: insights into central nervous system mechanism

  2024cites this paper
• Brain Glucose Metabolism and COMT Val 158 Met Polymorphism in Female Patients with Work-Related Stress

  2024cites this paper
• Hypometabolic patterns are related to post‐surgical seizure outcomes in focal cortical dysplasia: A semi‐quantitative study

  2024cites this paper
• Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study

  2024cites this paper
• Optimal filtering strategies for task-specific functional PET imaging

  2024cites this paper
• The mediating effect of 18F-FDG metabolism in right caudate between depressive symptoms and cognitive function in Alzheimer’s disease

  2024cites this paper
• Coupling motor evoked potentials and BRAIN [18F]FDG-pet in amyotrophic lateral sclerosis: Preliminary findings on disease severity.

  2024cites this paper
• Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study

  2024cites this paper
• Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms

  2024influential citation
• Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia.

  2024cites this paper
• FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose—a matched pair analysis

  2024cites this paper
• AI Diagnosis of Mild Cognitive Impairment in Neurodegenerative Diseases from FDG Pet Images

  2024cites this paper
• Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.

  2024cites this paper
• Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns.

  2024cites this paper
• Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18F-fluorodeoxyglucose pattern in a long-known syndrome

  2023cites this paper
• Objective Image Quality Comparison Between Brain-Dedicated PET and PET/CT Scanners

  2023cites this paper
• Frontal and anterior temporal hypometabolism post chemoradiation in head and neck cancer: A real‐world PET study

  2023cites this paper
• International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology

  2023cites this paper
• The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment

  2023cites this paper
• Suspecting Non-Alzheimer’s Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images

  2023cites this paper
• Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients

  2023cites this paper
• Comparing two picture naming tasks in Primary Progressive Aphasia: insights from behavioural and neural results

  2023cites this paper
• Metabolic profiles and correlation with surgical outcomes in mesial versus neocortical temporal lobe epilepsy

  2023cites this paper
• Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies

  2023cites this paper
• Resective epilepsy surgery in a limited-resource settings: A cohort from a multi-disciplinary epilepsy team in a developing country

  2023cites this paper
• Greater perceived stress management skills and heightened brain metabolic activity in cortical and subcortical stress processing regions in metastatic breast cancer patients

  2023cites this paper
• Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease

  2023cites this paper
• Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine

  2023cites this paper
• Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer’s Disease

  2023cites this paper
• Structural and metabolic brain correlates of arithmetic word‐problem solving in Huntington's disease

  2023cites this paper
• Siamese semi-disentanglement network for robust PET-CT segmentation

  2023cites this paper
• A Two-Branch Neural Network for Short-Axis PET Image Quality Enhancement

  2023cites this paper
• Functional FDG-PET: Measurement of Task Related Neural Activity in Humans—A Compartment Model Approach and Comparison to fMRI

  2023cites this paper
• Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis

  2023cites this paper
• Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.

  2023cites this paper
• Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography

  2022cites this paper
• Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease

  2022cites this paper
• Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data.

  2022cites this paper
• The Association Between Acquired Color Deficiency and PET Imaging of Neurodegeneration in Mild Cognitive Impairment and Alzheimer Disease

  2022cites this paper
• Reduced penetrance of an eastern French mutation in ATL1 autosomal-dominant inheritance (SPG3A): extended phenotypic spectrum coupled with brain 18F-FDG PET

  2022cites this paper
• The utility of 18F-FDG PET/CT in brain tumours diagnosis

  2022cites this paper
• Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline.

  2022cites this paper
• Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers

  2022cites this paper
• PET/MRI in the Presurgical Evaluation of Patients with Epilepsy: A Concordance Analysis

  2022cites this paper
• Brain Metabolism and Amyloid Load in Individuals With Subjective Cognitive Decline or Pre–Mild Cognitive Impairment

  2022cites this paper
• Blanching Defects at Pressure Points: Observations from Dynamic Total-Body PET/CT Studies

  2022cites this paper
• The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson’s Disease

  2022cites this paper
• Determination of optimal regularization factor in Bayesian penalized likelihood reconstruction of brain PET images using [18 F]FDG and [11 C]PiB.

  2022cites this paper
• Alterations in Cortical-Subcortical Metabolism in Temporal Lobe Epilepsy With Impaired Awareness Seizures

  2022cites this paper
• Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices

  2022cites this paper
• The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia

  2022cites this paper
• Processing speed dysfunction is associated with functional corticostriatal circuit alterations in childhood epilepsy with centrotemporal spikes: a PET and fMRI study

  2022cites this paper
• Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging

  2022cites this paper
• Assessing the impact of different penalty factors of the Bayesian reconstruction algorithm Q.Clear on in vivo low count kinetic analysis of [11C]PHNO brain PET-MR studies

  2022cites this paper
• The Impact of Accelerated HF-rTMS on Canine Brain Metabolism: An [18F]-FDG PET Study in Healthy Beagles

  2022cites this paper
• Abnormality Pattern of F-18 FDG PET Whole Body with Functional MRI Brain in Post-Acute COVID-19

  2022cites this paper
• Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment

  2022cites this paper
• Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes

  2022cites this paper
• Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies

  2022cites this paper
• Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap

  2022cites this paper
• Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide

  2022cites this paper
• Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting

  2022cites this paper
• Current update about instrumentation and utilization of PET-CT scan in oncology and human diseases

  2022cites this paper
• Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study

  2022cites this paper
• Automated differential diagnosis of dementia syndromes using FDG PET and machine learning

  2022cites this paper
• Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.

  2022cites this paper
• Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study.

  2022cites this paper
• Involvement of striatal motoric subregions in familial frontotemporal dementia with parkinsonism harboring the C9orf72 repeat expansions

  2022cites this paper
• Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis

  2022cites this paper
• Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L

  2022cites this paper
• International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease

  2022cites this paper